CD94-NKG2A receptors regulate antiviral CD8+T cell responses

被引:185
作者
Moser, JM
Gibbs, J
Jensen, PE
Lukacher, AE [1 ]
机构
[1] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA
[2] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1038/ni757
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD8(+) T lymphocytes mediate immunosurveillance against persistent virus infections and virus-induced neoplasia. Polyoma virus, a highly oncogenic natural mouse DNA virus, establishes persistent infection, but only a few mice are highly susceptible to tumors induced by the virus. Mature antiviral CD8(+) T cells expand in tumor-susceptible mice, but their cytotoxic effector activity is nonfunctional in vivo. Here we show that the natural killer cell inhibitory receptor, CD94-NKG2A, is up-regulated by antiviral CD8(+) T cells during acute polyoma infection and is responsible for down-regulating their antigen-specific cytotoxicity during both viral clearance and virus-induced oncogenesis.
引用
收藏
页码:189 / 195
页数:7
相关论文
共 51 条
[1]   Innate immune response of the human host to exposure with herpes simplex virus type 1: In vitro control of the virus infection by enhanced natural killer activity via interleukin-15 induction [J].
Ahmad, A ;
Sharif-Askari, E ;
Fawaz, L ;
Menezes, J .
JOURNAL OF VIROLOGY, 2000, 74 (16) :7196-7203
[2]   Viral activation of interleukin-15 (IL-15): Characterization of a virus-inducible element in the IL-15 promoter region [J].
Azimi, N ;
Tagaya, Y ;
Mariner, J ;
Waldmann, TA .
JOURNAL OF VIROLOGY, 2000, 74 (16) :7338-7348
[3]  
Bergmann CC, 1999, J IMMUNOL, V163, P3379
[4]   Interferons α and β as immune regulators -: A new look [J].
Biron, CA .
IMMUNITY, 2001, 14 (06) :661-664
[5]   HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C [J].
Braud, VM ;
Allan, DSJ ;
O'Callaghan, CA ;
Söderström, K ;
D'Andrea, A ;
Ogg, GS ;
Lazetic, S ;
Young, NT ;
Bell, JI ;
Phillips, JH ;
Lanier, LL ;
McMichael, AJ .
NATURE, 1998, 391 (6669) :795-799
[6]   Transgenic expression of Ly49A on T cells impairs a specific antitumor response [J].
Brawand, P ;
Lemonnier, FA ;
MacDonald, HR ;
Cerottini, JC ;
Held, W .
JOURNAL OF IMMUNOLOGY, 2000, 165 (04) :1871-1876
[7]  
Carretero M, 1998, EUR J IMMUNOL, V28, P1280, DOI 10.1002/(SICI)1521-4141(199804)28:04<1280::AID-IMMU1280>3.0.CO
[8]  
2-O
[9]  
Cerboni C, 2001, EUR J IMMUNOL, V31, P2926, DOI 10.1002/1521-4141(2001010)31:10<2926::AID-IMMU2926>3.0.CO
[10]  
2-2